デフォルト表紙
市場調査レポート
商品コード
1704188

失読症治療の世界市場レポート 2025年

Dyslexia Treatment Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
失読症治療の世界市場レポート 2025年
出版日: 2025年04月01日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

失読症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.0%で396億3,000万米ドルに成長します。予測期間における成長の背景には、ディスレクシアに対する保護者の意識の高まり、インクルーシブ教育政策やディスレクシア生徒のための専門教育プログラムの実施、ディスレクシアと診断されるケースの増加、教育者やセラピストのための継続的なトレーニングと開発プログラム、遠隔医療やオンライン治療サービスの台頭などがあります。予測期間における主な動向としては、早期診断とカスタマイズされた治療計画のための人工知能ツール、ソフトウェアベースの介入の利用、読書スキルの向上を支援するためのリアルタイム脳活動モニタリングの利用、失読症ユーザーの読み書きを支援するための高度な音声テキスト化アプリケーション、認知機能をモニタリングし、学習と集中を支援するためのフィードバックを提供するデバイスの需要などが挙げられます。

神経疾患の有病率の増加が、今後数年間の失読症治療市場の成長を促進すると予想されます。神経疾患には、脳、脊髄、神経などの神経系に影響を及ぼすさまざまな病状が含まれます。これらの疾患の有病率上昇の要因としては、人口の高齢化、ライフスタイルの変化、環境要因、より良い発見と報告につながる診断能力の向上などが挙げられます。多感覚学習や認知トレーニングなどのディスレクシアの治療は、脳の可塑性や認知機能を高めることによって神経症状を改善することが期待されています。2024年3月の世界保健機関(WHO)によると、世界全体で30億人以上が神経症状とともに生活しており、関連する死亡や健康被害の80%以上が低・中所得国で発生しています。治療へのアクセスにおける格差は大きく、高所得国では低・中所得国に比べ、一人当たりの神経専門医の数が大幅に多いです。したがって、神経疾患の有病率の増加が失読症治療市場成長の原動力となっています。

失読症治療市場の主要企業は、ホワイトノイズ機能などの高度なソリューションの開発に注力し、顧客により良いサポートを提供しています。ホワイトノイズ機能とは、特にADHDのような神経障害者に対して、一貫性のある音を提供することで、集中力、集中力、流暢な読書を向上させる聴覚ツールです。例えば、2024年10月、米国を拠点とするテクノロジー企業Promova Limitedは、ディスレクシアやその他の神経障害のある人が言語学習をより利用しやすくすることを目的とした拡張機能であるディスレクシアモード2.0を発表しました。オリジナルのディスレクシアモードをベースにした新バージョンでは、フォントサイズの調整、コントラストを下げるためのカラーシフト、読みやすさを向上させるための全角文字の削除などの機能強化が行われています。これらのアップデートは、視覚的ストレスを軽減し、神経ダイバージェント・ユーザーにより快適な学習体験を提供するために設計されています。ディスレクシア・モード2.0は、ディスレクシア・デザイナーのマーティン・ピスニーのような専門家の見識に基づいて開発され、学習上の課題を抱える人々の言語学習を向上させる、包括的でユーザーフレンドリーな環境を促進することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界失読症治療PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の失読症治療市場:成長率分析
  • 世界の失読症治療市場の実績:規模と成長, 2019-2024
  • 世界の失読症治療市場の予測:規模と成長, 2024-2029, 2034F
  • 世界失読症治療総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の失読症治療市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 二重欠陥ディスレクシア
  • 視覚性失読症
  • 音韻性失読症
  • その他のタイプ
  • 世界の失読症治療市場セラピーによって、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 作業療法
  • 言語療法
  • 認知行動療法
  • 世界の失読症治療市場薬物によって、実績と予測, 2019-2024, 2024-2029F, 2034F
  • シクリジン
  • メクリジン
  • ジメンヒドリナート
  • メチルフェニデート
  • その他の薬物
  • 世界の失読症治療市場:流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院薬局
  • 小売薬局
  • その他の流通チャネル
  • 世界の失読症治療市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 精神病院
  • リハビリテーションセンター
  • ホームケア
  • その他のエンドユーザー
  • 世界の失読症治療市場、二重欠陥ディスレクシアのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 音韻および視覚処理治療
  • 統合治療アプローチ
  • 世界の失読症治療市場視覚性失読症の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 視覚処理治療
  • 検眼と視覚療法
  • カラーオーバーレイセラピー
  • 世界の失読症治療市場音韻性失読症の分類(タイプ別)、実績と予測, 2019-2024, 2024-2029F, 2034F
  • フォニックスに基づく治療
  • 言語療法
  • 聴覚トレーニングとエクササイズ
  • 世界の失読症治療市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 急速命名失読症
  • 運動性失読症
  • 表層性失読症

第7章 地域別・国別分析

  • 世界の失読症治療市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の失読症治療市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 失読症治療市場:競合情勢
  • 失読症治療市場:企業プロファイル
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Astrazeneca Plc Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
    • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Purdue Pharma
  • Apotex Corporation
  • Endo International Plc
  • Amneal Pharmaceuticals LLC
  • Unither Pharmaceuticals LLC
  • RPG Life Sciences Ltd.
  • Jubilant Pharma Limited
  • Breckenridge Pharmaceutical Inc.
  • Rhodes Pharmaceuticals L.P.
  • Cian Healthcare Pvt. Ltd
  • Lexia Learning Systems LLC
  • Wallace Pharmaceuticals Ltd.
  • Ironshore Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 失読症治療市場2029:新たな機会を提供する国
  • 失読症治療市場2029:新たな機会を提供するセグメント
  • 失読症治療市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r30048

Treatment for dyslexia encompasses a variety of approaches and interventions aimed at enhancing the reading, writing, and spelling abilities of individuals with dyslexia. These typically involve specialized educational programs, including structured literacy and multisensory instruction, which utilize visual, auditory, and kinesthetic methods to support learning. Consistent practice, personalized assistance, and early intervention are crucial elements of effective dyslexia treatment.

There are several types of dyslexia treatment, such as double-deficit dyslexia, visual dyslexia, and phonological dyslexia. Double-deficit dyslexia involves challenges in both phonological processing (the ability to recognize the sound structure of words) and naming speed (the ability to quickly name letters and numbers). Therapy options for dyslexia include occupational therapy, speech therapy, and cognitive behavioral therapy, alongside medications such as cyclizine, meclizine, dimenhydrinate, methylphenidate, among others. These treatments are accessed through hospital pharmacies, retail pharmacies, and other distribution channels, catering to various end users such as psychiatric institutions, rehabilitation centers, and home care services.

The dyslexia treatment market research report is one of a series of new reports from The Business Research Company that provides dyslexia treatment market statistics, including dyslexia treatment industry global market size, regional shares, competitors with a dyslexia treatment market share, detailed dyslexia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the dyslexia treatment industry. This dyslexia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dyslexia treatment market size has grown strongly in recent years. It will grow from $28.19 billion in 2024 to $30.26 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to global collaboration and sharing of best practices, shifting societal attitudes towards learning disabilities, adoption of comprehensive treatment plans that incorporate psychological, educational, and medical interventions, enhanced funding from government and private sectors for research and educational programs, implementation of laws and regulations mandating support for students with learning disabilities.

The dyslexia treatment market size is expected to see strong growth in the next few years. It will grow to $39.63 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to growing awareness about dyslexia among parents, implementation of inclusive education policies and specialized educational programs for dyslexic students, an increase in the diagnosed cases of dyslexia, continuous training and development programs for educators and therapists, the rise of telehealth and online therapy services. Major trends in the forecast period include artificial intelligence tools for early diagnosis and customized treatment plans, the use of software-based interventions, the use of real-time brain activity monitoring to help individuals improve their reading skills, advanced speech-to-text applications to aid in reading and writing for dyslexic users, demand for devices that monitor cognitive functions and provide feedback to support learning and concentration.

The increasing prevalence of neurological disorders is expected to drive growth in the dyslexia treatment market in the coming years. Neurological disorders encompass a range of medical conditions affecting the nervous system, including the brain, spinal cord, and nerves. Factors contributing to the rising prevalence of these disorders include an aging population, changes in lifestyle, environmental factors, and improved diagnostic capabilities leading to better detection and reporting. Treatments for dyslexia, such as multisensory learning and cognitive training, hold promise for improving neurological conditions by enhancing brain plasticity and cognitive functions. According to the World Health Organization (WHO) in March 2024, more than 3 billion people globally were living with a neurological condition, with over 80% of related deaths and health losses occurring in low- and middle-income countries. Disparities in access to treatment are significant, with high-income countries having substantially more neurological professionals per capita compared to low- and middle-income countries. Therefore, the increasing prevalence of neurological disorders is a driving force behind the growth of the dyslexia treatment market.

Leading companies in the dyslexia treatment market are focusing on creating advanced solutions, such as the white noise feature, to better support customers. The white noise feature is an auditory tool that helps improve focus, concentration, and reading fluency, particularly for neurodivergent individuals, such as those with ADHD, by providing a consistent sound. For example, in October 2024, Promova Limited, a US-based technology company, introduced Dyslexia Mode 2.0, an enhanced feature aimed at making language learning more accessible for individuals with dyslexia and other neurodiverse conditions. Building on the original Dyslexia Mode, the new version includes enhancements such as adjustable font sizes, color shifting to reduce contrast, and the removal of all-caps text to improve readability. These updates are designed to reduce visual stress and offer a more comfortable learning experience for neurodivergent users. Developed with insights from experts like dyslexic designer Martin Pysny, Dyslexia Mode 2.0 aims to foster an inclusive, user-friendly environment that improves language learning for individuals with unique learning challenges.

In December 2022, Kyndryl Canada partnered with Dyslexia Canada to promote equitable access to education for students with dyslexia. This collaboration aims to raise awareness about the educational challenges faced by children and youth with dyslexia and to advocate for solutions that ensure fair and accessible education opportunities. Dyslexia Canada, a national charity based in Canada, is dedicated to improving the lives of children with dyslexia across the country.

Major companies operating in the dyslexia treatment market are Pfizer Inc., Astrazeneca Plc, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Purdue Pharma, Apotex Corporation, Endo International Plc, Amneal Pharmaceuticals LLC, Unither Pharmaceuticals LLC, RPG Life Sciences Ltd., Jubilant Pharma Limited, Breckenridge Pharmaceutical Inc., Rhodes Pharmaceuticals L.P., Cian Healthcare Pvt. Ltd, Lexia Learning Systems LLC, Wallace Pharmaceuticals Ltd., Ironshore Pharmaceuticals Inc., DK Pharmachem Pvt Ltd., Speechify Inc., Lingit AS, Lyfta, Nessy Learning Ltd.

North America was the largest region in the dyslexia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dyslexia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dyslexia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dyslexia treatment market consists of revenues earned by entities by services such as literacy programs, multisensory interventions, assistive technologies, individualized education plans, cognitive training, and therapies targeting visual and auditory processing skills. The market value includes the value of related goods sold by the service provider or included within the service offering. The dyslexia treatment market also includes sales of assistive listening devices, phonological processing tools, digital pens and notetaking devices, eye-tracking devices, and multi-sensory learning tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dyslexia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dyslexia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dyslexia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dyslexia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Double Deficit Dyslexia; Visual Dyslexia; Phonological Dyslexia; Other Types
  • 2) By Therapy: Occupational Therapy; Speech Therapy; Cognitive Behavioral Therapy
  • 3) By Drugs: Cyclizine; Meclizine; Dimenhydrinate; Methylphenidate; Other Drugs
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
  • 5) By End Users: Psychiatric Institutions; Rehabilitation Centers; Home Care; Other End-users
  • Subsegments:
  • 1) By Double Deficit Dyslexia: Phonological And Visual Processing Treatment; Integrated Therapy Approaches
  • 2) By Visual Dyslexia: Visual Processing Treatment; Optometric And Visual Therapy; Color Overlay Therapy
  • 3) By Phonological Dyslexia: Phonics-Based Treatment; Speech And Language Therapy; Auditory Training And Exercises
  • 4) By Other Types: Rapid Naming Dyslexia; Motor Dyslexia; Surface Dyslexia
  • Companies Mentioned: Pfizer Inc.; Astrazeneca Plc; Novartis AG; Takeda Pharmaceutical Company Limited; Eli Lilly and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dyslexia Treatment Market Characteristics

3. Dyslexia Treatment Market Trends And Strategies

4. Dyslexia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Dyslexia Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Dyslexia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Dyslexia Treatment Market Growth Rate Analysis
  • 5.4. Global Dyslexia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Dyslexia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Dyslexia Treatment Total Addressable Market (TAM)

6. Dyslexia Treatment Market Segmentation

  • 6.1. Global Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Double Deficit Dyslexia
  • Visual Dyslexia
  • Phonological Dyslexia
  • Other Types
  • 6.2. Global Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Occupational Therapy
  • Speech Therapy
  • Cognitive Behavioral Therapy
  • 6.3. Global Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cyclizine
  • Meclizine
  • Dimenhydrinate
  • Methylphenidate
  • Other Drugs
  • 6.4. Global Dyslexia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels
  • 6.5. Global Dyslexia Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Psychiatric Institutions
  • Rehabilitation Centers
  • Home Care
  • Other End-users
  • 6.6. Global Dyslexia Treatment Market, Sub-Segmentation Of Double Deficit Dyslexia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Phonological And Visual Processing Treatment
  • Integrated Therapy Approaches
  • 6.7. Global Dyslexia Treatment Market, Sub-Segmentation Of Visual Dyslexia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Visual Processing Treatment
  • Optometric And Visual Therapy
  • Color Overlay Therapy
  • 6.8. Global Dyslexia Treatment Market, Sub-Segmentation Of Phonological Dyslexia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Phonics-Based Treatment
  • Speech And Language Therapy
  • Auditory Training And Exercises
  • 6.9. Global Dyslexia Treatment Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rapid Naming Dyslexia
  • Motor Dyslexia
  • Surface Dyslexia

7. Dyslexia Treatment Market Regional And Country Analysis

  • 7.1. Global Dyslexia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Dyslexia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dyslexia Treatment Market

  • 8.1. Asia-Pacific Dyslexia Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dyslexia Treatment Market

  • 9.1. China Dyslexia Treatment Market Overview
  • 9.2. China Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dyslexia Treatment Market

  • 10.1. India Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dyslexia Treatment Market

  • 11.1. Japan Dyslexia Treatment Market Overview
  • 11.2. Japan Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dyslexia Treatment Market

  • 12.1. Australia Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dyslexia Treatment Market

  • 13.1. Indonesia Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dyslexia Treatment Market

  • 14.1. South Korea Dyslexia Treatment Market Overview
  • 14.2. South Korea Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dyslexia Treatment Market

  • 15.1. Western Europe Dyslexia Treatment Market Overview
  • 15.2. Western Europe Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dyslexia Treatment Market

  • 16.1. UK Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dyslexia Treatment Market

  • 17.1. Germany Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dyslexia Treatment Market

  • 18.1. France Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dyslexia Treatment Market

  • 19.1. Italy Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dyslexia Treatment Market

  • 20.1. Spain Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dyslexia Treatment Market

  • 21.1. Eastern Europe Dyslexia Treatment Market Overview
  • 21.2. Eastern Europe Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dyslexia Treatment Market

  • 22.1. Russia Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dyslexia Treatment Market

  • 23.1. North America Dyslexia Treatment Market Overview
  • 23.2. North America Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dyslexia Treatment Market

  • 24.1. USA Dyslexia Treatment Market Overview
  • 24.2. USA Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dyslexia Treatment Market

  • 25.1. Canada Dyslexia Treatment Market Overview
  • 25.2. Canada Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dyslexia Treatment Market

  • 26.1. South America Dyslexia Treatment Market Overview
  • 26.2. South America Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dyslexia Treatment Market

  • 27.1. Brazil Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dyslexia Treatment Market

  • 28.1. Middle East Dyslexia Treatment Market Overview
  • 28.2. Middle East Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dyslexia Treatment Market

  • 29.1. Africa Dyslexia Treatment Market Overview
  • 29.2. Africa Dyslexia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Dyslexia Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Dyslexia Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dyslexia Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Dyslexia Treatment Market Competitive Landscape
  • 30.2. Dyslexia Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Astrazeneca Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Dyslexia Treatment Market Other Major And Innovative Companies

  • 31.1. Viatris Inc.
  • 31.2. Teva Pharmaceutical Industries Ltd.
  • 31.3. Purdue Pharma
  • 31.4. Apotex Corporation
  • 31.5. Endo International Plc
  • 31.6. Amneal Pharmaceuticals LLC
  • 31.7. Unither Pharmaceuticals LLC
  • 31.8. RPG Life Sciences Ltd.
  • 31.9. Jubilant Pharma Limited
  • 31.10. Breckenridge Pharmaceutical Inc.
  • 31.11. Rhodes Pharmaceuticals L.P.
  • 31.12. Cian Healthcare Pvt. Ltd
  • 31.13. Lexia Learning Systems LLC
  • 31.14. Wallace Pharmaceuticals Ltd.
  • 31.15. Ironshore Pharmaceuticals Inc.

32. Global Dyslexia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dyslexia Treatment Market

34. Recent Developments In The Dyslexia Treatment Market

35. Dyslexia Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Dyslexia Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Dyslexia Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Dyslexia Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer